• Addressing the gap between early innovation and GMP-ready manufacturing for advanced modalities
• Integrating process analytical technologies and rapid analytics to enable real-time decisions
• Navigating validation and sterilization challenges for AAV and cell therapies
• Leveraging cross-sector collaboration to accelerate technology adoption and scale-up